Working... Menu

Efficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm (NODE-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02296190
Recruitment Status : Completed
First Posted : November 20, 2014
Last Update Posted : March 29, 2019
Medpace, Inc.
Information provided by (Responsible Party):
Milestone Pharmaceuticals Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2016
  Actual Study Completion Date : December 2016
  Certification/Extension First Submitted : March 18, 2019